# A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.

> **NCT02268929** · NA · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 414 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** Accu-Chek Smart Pix Software
- **DEVICE:** Accu-Chek Smart Pix readout Device

## Key facts

- **NCT ID:** NCT02268929
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-14
- **Primary completion:** 2017-01-11
- **Final completion:** 2017-02-09
- **Target enrollment:** 414 (ACTUAL)
- **Last updated:** 2017-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02268929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02268929, "A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02268929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*